Several computational approaches complemented the IHC-based assays to quantify and visualize CD3+ and CD8+ tumor-infiltrating lymphocytes (TILs) including Visiopharm, HALO image analysis, or other custom packages8–10. The gene discussed is CD8A; the disease is neoplasm.